Company / CapEx per Share
Bionano Genomics, Inc. CapEx per Share History
FY2018-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2020
5-year range
-
FY2018-FY2020
Trend
-94.6%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $13.17 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2020.
Declined from $13.17 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, capex per share decreased 94.6% year-over-year.
Company context
Key Data Points
- Altman Z-Score -8.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.00 | -94.6% |
| FY2019 | $0.03 | -99.7% |
| FY2018 | $13.17 | - |
As of FY2020 · SEC 10-K · Updated Jun 24, 2026